| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/13/2007 | US7189756 Pyrrolidine derivatives |
| 03/13/2007 | US7189755 Pyrrolidine melanocortin-specific compounds |
| 03/13/2007 | US7189751 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
| 03/13/2007 | US7189739 Antiinflammatory agents; cardiovascular disorders; rheumatic disorders |
| 03/13/2007 | US7189718 viricides; polymerase inhibitor; therapy for genetic engineered viruses |
| 03/13/2007 | US7189696 Peptide antagonists of zonulin and methods for use of the same |
| 03/13/2007 | US7189525 Human enzymes of the metalloprotease family |
| 03/13/2007 | US7189404 Strain selection of pneumococcal surface proteins |
| 03/13/2007 | US7189398 Amino acid sequence substantially homologous to the amino acid sequence of a fragment of a pyrogenic exotoxin, capable of eliciting protective immunity against toxic shock induced by a pyrogenic exotoxin |
| 03/13/2007 | US7189395 Complexes of immunoglobulins and polysaccharides for oral and transmucosal absorption |
| 03/13/2007 | US7189390 Probiotics for pet food applications |
| 03/13/2007 | US7189389 Pharmaceutical composition of human interferon-α2 and interferon α8 subtypes |
| 03/13/2007 | US7189351 D-tagatose as an anti-biofilm agent |
| 03/13/2007 | CA2420895C Method for treating erectile dysfunction and increasing libido in men |
| 03/13/2007 | CA2398182C Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 03/13/2007 | CA2387533C Purine derivatives |
| 03/13/2007 | CA2263336C Neuraminic acid compounds |
| 03/13/2007 | CA2259460C Recombinant canine adenovirus (cav) containing exogenous dna |
| 03/13/2007 | CA2253230C Antioxidant compounds |
| 03/13/2007 | CA2240494C Therapeutic molecules generated by trans-splicing |
| 03/13/2007 | CA2176181C D4t polymorphic form i process |
| 03/13/2007 | CA2167578C Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 03/13/2007 | CA2160922C Hiv immunogenic complexes |
| 03/13/2007 | CA2116388C Treatment for viral diseases |
| 03/13/2007 | CA2101463C Recombinant adenovirus vaccines |
| 03/13/2007 | CA1341522C Novel granulocyte colony stimulating factor polypeptide derivatives |
| 03/12/2007 | CA2559510A1 Compositions and methods for reducing vaginal ph |
| 03/12/2007 | CA2559407A1 Anhydrous composition containing an acid-acid buffer system |
| 03/08/2007 | WO2007027754A1 Bicyclic heterocycles as hiv integrase inhibitors |
| 03/08/2007 | WO2007027230A2 Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
| 03/08/2007 | WO2007027118A1 Dermatological composition |
| 03/08/2007 | WO2007026966A1 Thiomorpholine compound and process for preparing the same |
| 03/08/2007 | WO2007026157A1 Atm inhibitor |
| 03/08/2007 | WO2007026156A1 Pharmaceutical combinations containing lamivudine, stavudine and nevirapine |
| 03/08/2007 | WO2007026125A2 Anti-viral topical gel formulations containing a diuretic such as furosemide and/or a cardiac glycoside such as digoxin |
| 03/08/2007 | WO2007026024A2 Benzodiazepines as hcv inhibitors |
| 03/08/2007 | WO2007025999A1 Use of an aureolysin inhibitor for the treatment of inflammatory skin conditions characterised by colonisation with staphylococcus aureus |
| 03/08/2007 | WO2007025420A1 Low virulent strain of recombinant newcastle disease lasota vaccine expressing ha protein of avian influenza-h5 virus |
| 03/08/2007 | WO2007025390A1 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 03/08/2007 | WO2007011216A3 Bifunctional protein anchors |
| 03/08/2007 | WO2007011216A2 Bifunctional protein anchors |
| 03/08/2007 | WO2006128150A3 Crystalline solid forms of tigecycline and methods of preparing same |
| 03/08/2007 | WO2006122188A3 Tripeptides as hepatitis c virus inhibitors |
| 03/08/2007 | WO2006122012A3 Polymorphic forms of (s)- tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate |
| 03/08/2007 | WO2006120575A3 Tcr-independent activation of t cells with co-lignation of cd28 and cd81 |
| 03/08/2007 | WO2006105021A3 Gitr binding molecules and uses therefor |
| 03/08/2007 | WO2006098624A3 Anti-viral use of a coumarin agent |
| 03/08/2007 | WO2006084910A3 Device and method for treatment of dermatomycosis, and in particular onychomycosis |
| 03/08/2007 | WO2006067392A3 Indole derivatives for the treatment of tuberculosis |
| 03/08/2007 | WO2005110486A3 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists |
| 03/08/2007 | US20070055459 Structure-based approach to design of protein-processivity factor interactions |
| 03/08/2007 | US20070054913 4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 03/08/2007 | US20070054904 Phenol derivatives and their use as rotamase inhibitors |
| 03/08/2007 | US20070054883 Use controlling growth of quorum-sensing bacteria, controlling biofilm formation, including biofilm growth; cyclic borate, phosphate or sulfate compounds |
| 03/08/2007 | US20070054877 Antiadhesive carbohydrates |
| 03/08/2007 | US20070054861 Therapeutic uses of SMR1 peptides |
| 03/08/2007 | US20070054364 Polypeptide variants |
| 03/08/2007 | US20070054312 Human transmembrane proteins |
| 03/08/2007 | US20070053973 Amorphous antibiotic composition comprising cefditoren pivoxil |
| 03/08/2007 | US20070053942 Disinfectant and/or bactericidal aqueous compositions |
| 03/08/2007 | US20070053926 Antigenic neisserial peptides |
| 03/08/2007 | US20070053922 Epitope based vaccines directed towards HPV; side effect reduction; vaccination |
| 03/08/2007 | US20070053916 Plasmodium falciparum peptide for use in stimulating immune response to treat and prevent malaria |
| 03/08/2007 | US20070053878 Sars |
| 03/08/2007 | US20070053833 Hydrating a leukemia patient; parenterally administering a dose samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and melphalan, busulfan, and/or cyclophosphamiide; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 03/08/2007 | CA2621201A1 Topical formulations |
| 03/08/2007 | CA2621200A1 Transdermal active principle delivery means |
| 03/08/2007 | CA2621037A1 Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents |
| 03/08/2007 | CA2620853A1 Pharmaceutical combinations containing lamivudine, stavudine and nevirapine |
| 03/08/2007 | CA2620777A1 Benzodiazepines as hcv inhibitors |
| 03/08/2007 | CA2620774A1 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 03/08/2007 | CA2620742A1 Thiomorpholine compound and process for preparing the same |
| 03/08/2007 | CA2620022A1 Use of an aureolysin inhibitor for the treatment of inflammatory skin conditions characterised by colonisation with staphylococcus aureus |
| 03/08/2007 | CA2616561A1 Therapeutic goose antibodies for treatment and prophylaxis of transmittable viral diseases |
| 03/08/2007 | CA2616468A1 Tricyclic 6-alkylidene-penem .beta.-lactamase inhibitors and .beta.-lactam antibiotic combination: a broad spectrum antibiotic |
| 03/08/2007 | CA2606106A1 Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
| 03/07/2007 | EP1760090A1 Regulatory/unfolding peptides of ezrin |
| 03/07/2007 | EP1760083A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 03/07/2007 | EP1760079A1 Compounds as cor5 antagonists |
| 03/07/2007 | EP1760076A1 FAP Inhibitors |
| 03/07/2007 | EP1759710A1 Remedy or preventive for arthritis |
| 03/07/2007 | EP1759703A1 Immunistimulative and interferonogenous agent |
| 03/07/2007 | EP1759597A2 Antiallergic composition |
| 03/07/2007 | EP1758915A2 Composition and method for inhibiting platelet aggregation |
| 03/07/2007 | EP1758857A1 Indole derivatives as antiviral agents |
| 03/07/2007 | EP1758640A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 03/07/2007 | EP1758585A2 Hiv integrase inhibitors |
| 03/07/2007 | EP1758581A1 Combinations comprising a 4-isoquinolone derivative and anti-hiv agents |
| 03/07/2007 | EP1758469A2 Improvement of barrier integrarity in hiv patients by use of fatty acids |
| 03/07/2007 | EP1689731B1 2-phenyl-benzofuran derivatives, method for the production thereof and their use |
| 03/07/2007 | EP1646646B1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof. |
| 03/07/2007 | EP1562615A4 Oral and dental composition |
| 03/07/2007 | EP1461342B1 Streptogramin derivatives, preparation thereof and compositions containing same |
| 03/07/2007 | EP1427728B1 6,7-DIHYDRO-5H-PYRAZOLO 1,2-A PYRAZOL-1-ONES WHICH CONTROL INFLAMMATORY cYTOKINES |
| 03/07/2007 | EP1395283B1 Heterologous protection induced by immunization with invaplex vaccine |
| 03/07/2007 | EP1368304B1 Prodrugs of excitatory amino acids |
| 03/07/2007 | EP1352061B9 Method for inhibiting the expression of a target gene |
| 03/07/2007 | EP1333840B1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 03/07/2007 | EP1313449B1 Amphotericin b structured emulsion |
| 03/07/2007 | EP1210445B1 Recombinant microorganisms |